We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

75 hedge funds and large institutions have $335M invested in Abeona Therapeutics in 2017 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

544% more call options, than puts

Call options by funds: $27.1M | Put options by funds: $4.21M

239% more capital invested

Capital invested by funds: $98.6M → $335M (+$236M)

93% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 15

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

7% more funds holding

Funds holding: 70 → 75 (+5)

0.42% more ownership

Funds ownership: 1.53% → 1.95% (+0.42%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
75
Holders Change
+5
Holders Change %
+7.14%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
29
Reduced
15
Closed
11
Calls
$27.1M
Puts
$4.21M
Net Calls
+$22.9M
Net Calls Change
+$19M

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$24.1M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.4M
3
CHP
Castle Hook Partners
New York
+$4.35M
4
BlackRock
BlackRock
New York
+$4.18M
5
PC
PointState Capital
New York
+$4.06M

Top Sellers

Rank Fund Capital Flow
1
SFM
Soros Fund Management
New York
-$5.74M
2
HCM
Highbridge Capital Management
New York
-$4.27M
3
NC
Nexthera Capital
New York
-$3.81M
4
PA
Perceptive Advisors
New York
-$3.29M
5
JGC
J. Goldman & Co
New York
-$3.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
26
Perceptive Advisors
New York
$1.99M -$3.29M -12,239 -72%
Group One Trading
27
Group One Trading
Illinois
$1.81M +$1.01M +3,746 +764%
Allianz Asset Management
28
Allianz Asset Management
Germany
$1.77M -$204K -759 -15%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.76M +$32.2K +120 +3%
Citigroup
30
Citigroup
New York
$1.67M +$1.05M +3,900 +21,667%
BGIM
31
Brandywine Global Investment Management
Pennsylvania
$1.53M +$962K +3,578 New
TCIM
32
TIAA CREF Investment Management
New York
$1.16M +$6.45K +24 +0.9%
CT
33
Cambridge Trust
Massachusetts
$1.11M – – –
AAP
34
Ardsley Advisory Partners
Connecticut
$853K -$107K -400 -17%
TA
35
Teachers Advisors
New York
$756K – – –
AQR Capital Management
36
AQR Capital Management
Connecticut
$750K +$473K +1,760 New
Morgan Stanley
37
Morgan Stanley
New York
$708K +$56.2K +209 +14%
Charles Schwab
38
Charles Schwab
California
$701K – – –
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$660K -$44.9K -167 -10%
EIM
40
Essex Investment Management
Massachusetts
$656K -$584K -2,175 -59%
FM
41
Family Management
New York
$614K +$129K +480 +50%
Wells Fargo
42
Wells Fargo
California
$600K +$368K +1,369 +3,423%
Tudor Investment Corp
43
Tudor Investment Corp
Connecticut
$547K +$345K +1,284 New
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$505K +$269 +1 +0.1%
MCM
45
Moore Capital Management
New York
$426K -$806K -3,000 -75%
IA
46
IFP Advisors
Florida
$426K – – –
CS
47
Credit Suisse
Switzerland
$408K +$257K +958 New
JGC
48
J. Goldman & Co
New York
$396K -$3.03M -11,272 -92%
PCM
49
Prelude Capital Management
New York
$387K -$257K -958 -51%
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$351K – – –
1
2
3 4

ABEO Hedge Fund Activity: Q3 2017 in Review

75 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2017, worth a combined $335M — up 239% from $98.6M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ABEO positions and 11 closed out — a net gain of 5 holders — while 29 added to existing stakes and 15 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $24.1M. The largest seller was Soros Fund Management, exiting entirely with an estimated $5.74M sold.

  • 75 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2017, up from 70 in Q2 2017.
  • Funds reported $335M of Abeona Therapeutics stock for Q3 2017, up 239% quarter-over-quarter.
  • 16 funds opened new Abeona Therapeutics positions in Q3 2017 and 11 closed out, a net change of +5 holders.
  • The largest Abeona Therapeutics buyer in Q3 2017 was Viking Global Investors, an estimated $24.1M added.
  • The largest Abeona Therapeutics seller in Q3 2017 was Soros Fund Management, an estimated $5.74M sold.

Based on aggregated 13F filings for Q3 2017.